Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-30 14:50 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
Filed 2024-09-27 16:19 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,512,069 | |
Filed 2024-09-27 16:17 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
2,280,786 | |
Filed 2024-09-27 16:14 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Lalji, Karim Fatehali
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
Filed 2024-09-27 16:13 Tx date 2024-08-14 |
$MDNA
Medicenna Therapeutics Corp. |
Lalji, Karim Fatehali
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-09-27 16:11 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Sampson, John Howard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
285,691 | |
Filed 2024-09-27 16:09 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
376,346 | |
Filed 2024-09-27 16:07 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
301,346 | |
Filed 2024-09-27 16:02 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
526,346 | |
Filed 2024-06-10 17:01 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$131,666
+346,490 vol $0.38 each |
5,596,490 | |
Filed 2024-06-10 17:00 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-450,000 vol |
1,212,069 | |
Filed 2024-06-10 16:56 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$156,332
+411,402 vol $0.38 each |
5,762,802 | |
Filed 2024-06-10 16:55 Tx date 2024-06-03 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-550,000 vol |
1,930,786 | |
Filed 2024-01-16 17:03 Tx date 2024-01-15 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
Filed 2023-12-22 11:00 Tx date 2023-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |
Filed 2023-12-22 10:58 Tx date 2023-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |
Filed 2023-10-03 09:23 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Caravella, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2023-10-03 09:22 Tx date 2023-08-28 |
$MDNA
Medicenna Therapeutics Corp. |
Caravella, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-10-03 09:21 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Meadows, Richard Brent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2023-10-03 09:20 Tx date 2023-08-01 |
$MDNA
Medicenna Therapeutics Corp. |
Meadows, Richard Brent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-10-02 21:43 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Sampson, John Howard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
185,691 | |
Filed 2023-10-02 21:40 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
276,346 | |
Filed 2023-10-02 21:38 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
201,346 | |
Filed 2023-10-02 21:36 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
426,346 | |
Filed 2023-10-02 21:33 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,662,069 | |
Filed 2023-10-02 21:27 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,480,786 | |
Filed 2023-09-01 10:07 Tx date 2023-08-28 |
$MDNA
Medicenna Therapeutics Corp. |
Caravella, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-23 10:44 Tx date 2023-08-01 |
$MDNA
Medicenna Therapeutics Corp. |
Meadows, Richard Brent
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-02-22 16:15 Tx date 2023-02-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,600
+30,000 vol $0.92 each |
5,351,400 | |
Filed 2022-10-24 16:31 Tx date 2022-09-29 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$790.00
+1,000 vol $0.79 each |
3,000 | |
Filed 2022-09-30 10:56 Tx date 2022-09-29 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$790.00
+1,000 vol $0.79 each |
||
Filed 2022-10-17 13:13 Tx date 2022-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-21,875
-12,500 vol $1.75 each |
0 | |
Filed 2022-10-17 13:10 Tx date 2022-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-175,000
-100,000 vol $1.75 each |
0 | |
Filed 2022-10-11 13:49 Tx date 2022-10-11 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,482
+25,000 vol $1.18 each |
325,000 | |
Filed 2022-10-11 13:49 Tx date 2022-10-07 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,405
+4,700 vol $1.15 each |
300,000 | |
Filed 2022-10-11 13:48 Tx date 2022-10-06 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,439
+5,600 vol $1.15 each |
295,300 | |
Filed 2022-10-06 10:29 Tx date 2022-10-05 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,470
+17,800 vol $1.15 each |
289,700 | |
Filed 2022-10-06 10:28 Tx date 2022-10-04 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,287
+46,900 vol $1.14 each |
271,900 | |
Filed 2022-09-30 10:56 Tx date 2022-09-29 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$790.00
+1,000 vol $0.79 each |
3,000 | |
Filed 2022-06-29 12:45 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
326,346 | |
Filed 2022-06-28 17:34 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
326,346 | |
Filed 2022-06-28 17:30 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$259,349
+178,862 vol $1.45 each |
827,463 | |
Filed 2022-06-28 16:10 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,239
+238,786 vol $1.45 each |
1,162,069 | |
Filed 2022-06-28 16:07 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$587,250
+405,000 vol $1.45 each |
1,980,786 | |
Filed 2022-06-28 16:03 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Sampson, John Howard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
85,691 | |
Filed 2022-06-28 16:00 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
101,346 | |
Filed 2022-06-28 15:57 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
176,346 | |
Filed 2022-03-09 14:59 Tx date 2022-03-09 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+5,000 vol $1.80 each |
15,300 | |
Filed 2022-01-21 10:54 Tx date 2022-01-19 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$962.00
+500 vol $1.92 each |
5,321,400 | |
Filed 2022-01-21 10:53 Tx date 2022-01-19 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,552
+800 vol $1.94 each |
5,320,900 | |
Filed 2022-01-21 10:52 Tx date 2022-01-19 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,061
+11,700 vol $1.89 each |
5,320,100 | |
Filed 2021-11-15 09:09 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
267,725 | |
Filed 2021-09-24 17:31 Tx date 2021-09-16 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
||
Filed 2021-11-08 13:06 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,690
+24,700 vol $2.70 each |
5,308,400 | |
Filed 2021-11-08 13:06 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,643
+4,700 vol $2.69 each |
5,283,700 | |
Filed 2021-11-08 13:06 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$268.00
+100 vol $2.68 each |
5,279,000 | |
Filed 2021-11-08 13:05 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,370
+5,800 vol $2.65 each |
5,278,900 | |
Filed 2021-11-08 13:05 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$264.00
+100 vol $2.64 each |
5,273,100 | |
Filed 2021-11-08 13:05 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,786
+2,200 vol $2.63 each |
5,273,000 | |
Filed 2021-11-08 13:04 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,454
+1,700 vol $2.62 each |
5,270,800 | |
Filed 2021-11-08 13:04 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260.00
+100 vol $2.60 each |
5,269,100 | |
Filed 2021-11-05 13:22 Tx date 2021-11-05 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,315
+500 vol $2.63 each |
2,000 | |
Filed 2021-11-03 15:17 Tx date 2021-11-02 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,975
+9,000 vol $2.77 each |
5,269,000 | |
Filed 2021-11-01 16:29 Tx date 2021-11-01 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,982
+4,000 vol $2.75 each |
10,300 | |
Filed 2021-09-30 15:19 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Sampson, John Howard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
27,070 | |
Filed 2021-09-30 15:17 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Sampson, John Howard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-24 17:40 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$213,749
+68,073 vol $3.14 each |
648,601 | |
Filed 2021-09-24 17:36 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$278,348
+88,646 vol $3.14 each |
923,283 | |
Filed 2021-09-24 17:34 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$623,249
+198,487 vol $3.14 each |
1,575,786 | |
Filed 2021-09-24 17:31 Tx date 2021-09-16 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
267,725 | |
Filed 2021-09-24 16:19 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Moulder, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,200
+30,000 vol $3.14 each |
30,000 | |
Filed 2021-09-24 16:19 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Moulder, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-110,000 vol |
0 | |
Filed 2021-09-24 16:15 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
42,725 | |
Filed 2021-09-24 16:12 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
117,725 | |
Filed 2021-09-24 16:09 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
267,725 | |
Filed 2021-05-16 20:04 Tx date 2021-05-10 |
$MDNA
Medicenna Therapeutics Corp. |
Muhsin, Maan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$825,100
+185,000 vol $4.46 each |
185,000 | |
Filed 2021-05-16 20:03 Tx date 2021-05-10 |
$MDNA
Medicenna Therapeutics Corp. |
Muhsin, Maan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-04-22 10:21 Tx date 2021-04-20 |
$MDNA
Medicenna Therapeutics Corp. |
Moulder, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$533,500
+110,000 vol $4.85 each |
110,000 | |
Filed 2021-04-22 10:19 Tx date 2021-04-19 |
$MDNA
Medicenna Therapeutics Corp. |
Moulder, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-07 09:34 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,220
+1,000 vol $5.22 each |
6,300 | |
Filed 2021-01-07 09:30 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,656
+9,200 vol $5.18 each |
5,260,000 | |
Filed 2021-01-07 09:29 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,068
+400 vol $5.17 each |
5,250,800 | |
Filed 2021-01-07 09:28 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,028
+200 vol $5.14 each |
5,250,400 | |
Filed 2021-01-07 09:28 Tx date 2021-01-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,026
+200 vol $5.13 each |
5,250,200 | |
Filed 2020-11-06 16:04 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
15,655 | |
Filed 2020-11-06 16:03 Tx date 2020-09-30 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-05 10:38 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
240,655 | |
Filed 2020-11-05 09:22 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
240,655 | |
Filed 2020-11-05 09:18 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$176,995
+34,637 vol $5.11 each |
834,637 | |
Filed 2020-11-05 09:15 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$394,997
+77,299 vol $5.11 each |
1,377,299 | |
Filed 2020-11-05 09:14 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,998
+30,528 vol $5.11 each |
580,528 | |
Filed 2020-11-05 09:09 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
90,655 | |
Filed 2019-11-13 06:39 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+75,000 vol $1.30 each |
225,000 | |
Filed 2019-11-11 16:26 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$195,000
+150,000 vol $1.30 each |
550,000 | |
Filed 2019-11-11 16:24 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$260,000
+200,000 vol $1.30 each |
800,000 | |
Filed 2019-11-11 16:22 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$390,000
+300,000 vol $1.30 each |
1,300,000 | |
Filed 2019-11-11 16:17 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+75,000 vol $1.30 each |
75,000 | |
Filed 2019-11-11 16:17 Tx date 2019-09-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-11 16:15 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+75,000 vol $1.30 each |
225,000 | |
Filed 2019-11-11 16:13 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+75,000 vol $1.30 each |
225,000 | |
Filed 2019-10-18 14:29 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$175,000
+100,000 vol $1.75 each |
100,000 | |
Filed 2019-10-18 14:28 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-18 14:28 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$260,000
+200,000 vol $1.30 each |
225,000 | |
Filed 2019-10-18 14:22 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$21,875
+12,500 vol $1.75 each |
12,500 | |
Filed 2019-10-18 14:22 Tx date 2019-09-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-18 14:22 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$32,500
+25,000 vol $1.30 each |
25,000 | |
Filed 2019-10-18 14:21 Tx date 2019-09-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-18 14:20 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$43,750
+25,000 vol $1.75 each |
25,000 | |
Filed 2019-10-18 14:20 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-18 14:19 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$65,000
+50,000 vol $1.30 each |
50,000 | |
Filed 2019-10-18 14:18 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+50,000 vol $1.00 each |
150,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+200,000 vol $1.00 each |
400,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+200,000 vol $1.00 each |
600,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+300,000 vol $1.00 each |
1,000,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Li, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+50,000 vol $1.00 each |
100,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+50,000 vol $1.00 each |
150,000 | |
Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+50,000 vol $1.00 each |
150,000 | |
Filed 2018-12-27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$120,000
+100,000 vol $1.20 each |
100,000 | |
Filed 2018-12-27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-27 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$120,000
+100,000 vol $1.20 each |
100,000 | |
Filed 2018-12-22 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,000
+200,000 vol $1.00 each |
5,250,000 | |
Filed 2018-12-22 Tx date 2018-12-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,000
+200,000 vol $1.00 each |
5,250,000 | |
Filed 2018-08-28 Tx date 2018-08-27 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,070
+3,700 vol $1.10 each |
25,000 | |
Filed 2018-08-27 Tx date 2018-08-24 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,488
+1,400 vol $1.06 each |
||
Filed 2018-08-27 Tx date 2018-08-22 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,492
+19,900 vol $1.08 each |
19,900 | |
Filed 2018-08-27 Tx date 2018-08-22 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,488
+1,400 vol $1.06 each |
21,300 | |
Filed 2018-08-27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-22 Tx date 2018-08-22 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$500.00
+500 vol $1.00 each |
1,500 | |
Filed 2017-11-15 Tx date 2017-11-10 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,000
+50,000 vol $2.88 each |
100,000 | |
Filed 2017-11-15 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2017-11-14 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
Li, William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-14 Tx date 2017-11-10 |
$MDNA
Medicenna Therapeutics Corp. |
Li, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,000
+50,000 vol $2.88 each |
50,000 | |
Filed 2017-11-13 Tx date 2017-11-10 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,000
+50,000 vol $2.88 each |
100,000 | |
Filed 2017-11-13 Tx date 2017-11-10 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,000
+50,000 vol $2.88 each |
100,000 | |
Filed 2017-09-26 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,749
+75,000 vol $2.01 each |
200,000 | |
Filed 2017-09-26 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$301,499
+150,000 vol $2.01 each |
400,000 | |
Filed 2017-09-26 Tx date 2017-09-21 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$703,499
+350,000 vol $2.01 each |
700,000 | |
Filed 2017-09-06 Tx date 2017-09-06 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+250 vol $1.50 each |
1,000 | |
Filed 2017-06-20 Tx date 2017-06-20 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$106.00
+50 vol $2.12 each |
50 | |
Filed 2017-06-20 Tx date 2017-06-20 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,075
+500 vol $2.15 each |
750 | |
Filed 2017-06-20 Tx date 2017-06-20 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+200 vol $2.00 each |
250 | |
Filed 2017-06-20 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Panchal, Chandra
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,500,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,050,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,500,000 | ||
Filed 2017-03-21 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,050,000 | ||
Filed 2017-03-13 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Ward, Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
Filed 2017-03-13 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
Filed 2017-03-13 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Williams, Elizabeth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,300 | ||
Filed 2017-03-13 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Strong, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2017-03-02 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Wong-Chor, Trevor
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-9,286 vol |
714 |